Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease

Objectives: To explore serum zinc-α2-glycoprotein (ZAG) changes in patients with or without premature coronary artery disease (PCAD) and its association with several cardiovascular risk factors.Methods: A total of 3,364 patients who were undergone coronary angiography in Peking Union Medical College...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Meijuan Liu, Huijuan Zhu, Tianshu Zhai, Hui Pan, Linjie Wang, Hongbo Yang, Kemin Yan, Yong Zeng, Fengying Gong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2019-03-01
coleção:	Frontiers in Endocrinology
Assuntos:	zinc-α2-glycoprotein (ZAG) premature coronary artery disease (PCAD) non-premature coronary artery disease (NPCAD) body mass index (BMI) diagnostic biomarker
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fendo.2019.00197/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!